Ausgewählte Publikationen
J. Weber, C. J. Braun, D. Saur, R. Rad, "In vivo functional screening for systems-level integrative cancer genomics," Nature Reviews Cancer, 2020 (JIF 2019: 53.030). Link
M. Becker, H. Noll-Puchta, D. Amend, F. Nolte, C. Fuchs, I. Jeremias*, C. J. Braun*, "CLUE: a bioinformatic and wet-lab pipeline for multiplexed cloning of custom sgRNA libraries," Nucleic Acids Research, 2020 (JIF 2019: 11.501). Link
C. J. Braun*, M. Stanciu*, P. L. Boutz*, J. C. Patterson, D. Calligaris, F. Higuchi, R. Neupane, S. Fenoglio, D. P. Cahill, H. Wakimoto, N. Y. R. Agar, M. B. Yaffe, P. A. Sharp, M. T. Hemann, J. A. Lees, “Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma,” Cancer Cell, 2017 (JIF 2019: 26.602). Link
C. J. Braun*, P. M. Bruno*, M. A. Horlbeck, L. A. Gilbert, J. S. Weissman, M. T. Hemann, “Versatile in vivo regulation of tumor phenotypes by dCas9 mediated transcriptional perturbation,” PNAS, 2016 (JIF 2019: 9.412). Link
C. J. Braun*, K. Boztug*, A. Paruzynski*, M. Witzel*, A. Schwarzer, M. Rothe, U. Modlich, R. Beier, G. Göhring, D. Steinemann, R. Fronza, C. R. Ball, R. Haemmerle, S. Naundorf, K. Kühlcke, M. Rose, C. Fraser, L. Mathias, R. Ferrari, M. R. Abboud, W. Al-Herz, I. Kondratenko, L. Maródi, H. Glimm, B. Schlegelberger, A. Schambach, M. H. Albert, M. Schmidt, C. von Kalle, and C. Klein, “Gene Therapy for Wiskott-Aldrich Syndrome--long-term efficacy and genotoxicity.,” Sci Transl Med, 2014 (JIF 2019: 16.304). Link
C. P. Pallasch, I. Leskov, C. J. Braun, D. Vorholt, A. Drake, Y. M. Soto-Feliciano, E. H. Bent, J. Schwamb, B. Iliopoulou, N. Kutsch, N. van Rooijen, L. P. Frenzel, C. M. Wendtner, L. Heukamp, K. A. Kreuzer, M. Hallek, J. Chen, and M. T. Hemann, “Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy,” Cell, 2014 (JIF 2019: 38.637). Link
I. G. Cannell, K. A. Merrick*, S. Morandell*, C. Z. Zhu, C. J. Braun, R. A. Grant, E. R. Cameron, M. Tsao, M.T. Hemann and M. B. Yaffe. “A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-defective Tumors to Chemotherapy,” Cancer Cell, 2015 (JIF 2019: 26.602). Link
*equal contributions
